JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SAGE
1026
DELISTED
Sage Therapeutics
SAGE
| $57.7M | 0.01% |
1,375,318
-37,513
| -3% | -$1.61M |
2014 Q3
34 quarters
|
|
1027
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.48B
| $57.6M | 0.01% |
722,839
+661,939
| +1,087% | +$52.2M |
2015 Q4
29 quarters
|
|
1028
Aflac
AFL
$55.9B
| $57.6M | 0.01% |
892,619
+117,333
| +15% | +$8.03M |
2013 Q2
39 quarters
|
|
1029
Genesis Energy
GEL
$1.72B
| $57.5M | 0.01% |
5,109,799
-222,335
| -4% | -$2.5M |
2013 Q2
39 quarters
|
|
1030
iShares MSCI USA Momentum Factor ETF
MTUM
$21.3B
| $57.4M | 0.01% |
412,554
-249,004
| -38% | -$35.1M |
2015 Q1
32 quarters
|
|
1031
CALL
Cisco
CSCO
$442B
| $57.3M | 0.01% |
1,096,800
+151,300
| +16% | +$7.39M |
2016 Q2
27 quarters
|
|
1032
PUT
Madrigal Pharmaceuticals
MDGL
$11.5B
| $57.3M | 0.01% |
236,600
+205,200
| +654% | +$55.9M |
2022 Q3
2 quarters
|
|
1033
CALL
Blackstone
BX
$83.9B
| $57.1M | 0.01% |
650,400
+600,400
| +1,201% | +$53M |
2022 Q2
3 quarters
|
|
1034
Sunoco
SUN
$14.1B
| $57.1M | 0.01% |
1,301,536
-52,696
| -4% | -$2.37M |
2014 Q3
34 quarters
|
|
1035
Academy Sports + Outdoors
ASO
$3B
| $57.1M | 0.01% |
874,923
+100,031
| +13% | +$5.89M |
2020 Q4
9 quarters
|
|
1036
Eversource Energy
ES
$24.3B
| $57M | 0.01% |
728,936
+204,757
| +39% | +$16.2M |
2013 Q2
39 quarters
|
|
1037
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $57M | 0.01% |
2,573,615
-290,433
| -10% | -$6.63M |
2016 Q2
27 quarters
|
|
1038
Church & Dwight Co
CHD
$22.4B
| $56.8M | 0.01% |
642,296
+45,284
| +8% | +$3.78M |
2013 Q2
39 quarters
|
|
1039
Americold
COLD
$3.99B
| $56.7M | 0.01% |
1,992,197
+38,075
| +2% | +$1.14M |
2018 Q1
20 quarters
|
|
1040
GE HealthCare
GEHC
$29B
| $56.6M | 0.01% |
690,553
+642,598
| +1,340% | +$45.9M |
2022 Q4
1 quarter
|
|
1041
Gen Digital
GEN
$13.2B
| $56.4M | 0.01% |
3,284,699
-3,628,982
| -52% | -$72.8M |
2013 Q2
39 quarters
|
|
1042
Reliance Steel & Aluminium
RS
$20.4B
| $56.3M | 0.01% |
219,229
+29,112
| +15% | +$6.86M |
2013 Q2
39 quarters
|
|
1043
Box
BOX
$4.73B
| $56M | 0.01% |
2,091,076
+1,436,539
| +219% | +$43.3M |
2015 Q3
30 quarters
|
|
|
OSH
1044
DELISTED
Oak Street Health, Inc.
OSH
| $55.8M | 0.01% |
1,443,648
+1,373,687
| +1,964% | +$44.3M |
2020 Q3
10 quarters
|
|
1045
NetEase
NTES
$75.1B
| $55.8M | 0.01% |
630,506
+546,566
| +651% | +$47.1M |
2013 Q2
39 quarters
|
|
1046
ACV Auctions
ACVA
$1.77B
| $55.7M | 0.01% |
4,314,089
+213,799
| +5% | +$2.34M |
2021 Q1
8 quarters
|
|
1047
Old National Bancorp
ONB
$9.55B
| $55.7M | 0.01% |
3,861,349
+295,388
| +8% | +$5M |
2013 Q2
39 quarters
|
|
1048
Advanced Drainage Systems
WMS
$9.6B
| $55.5M | 0.01% |
658,707
+120,259
| +22% | +$10.6M |
2014 Q4
33 quarters
|
|
1049
Commercial Metals
CMC
$7.03B
| $55.4M | 0.01% |
1,133,283
+72,305
| +7% | +$3.75M |
2013 Q2
39 quarters
|
|
1050
Berkshire Hathaway Class A
BRK.A
$1.08T
| $55.4M | 0.01% |
119
-33
| -22% | -$15.4M |
2015 Q3
30 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.